Concepedia

Scott Grimm

SG

Statistics

Publications

41

Citations

3.1K

H-Index

22

Active since

1991

Affiliations

AstraZeneca (United States)(Current)

Wilmington University

University of Rochester

University of Arizona

Stanford University

Scott Grimm is an author at AstraZeneca (United States) specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1991–2021

41

Publications

41

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations

, , +17

The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · The Journal of Clinical Pharmacology · 2003 · 309 citations

, , +17

The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

Scott Grimm, Heidi J. Einolf, Steven D. Hall et al. · Drug Metabolism and Disposition · 2009 · 306 citations

, , +17

ATP-DEPENDENT TRANSPORT OF ROSUVASTATIN IN MEMBRANE VESICLES EXPRESSING BREAST CANCER RESISTANCE PROTEIN

Liyue Huang, Yi Wang, Scott Grimm · Drug Metabolism and Disposition · 2006 · 166 citations

, , +17

Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics

Scott Grimm, Neil M. Richtand, Helen Winter et al. · British Journal of Clinical Pharmacology · 2005 · 164 citations · Full text

, , +13

1–5 of 41